Search Results 1311-1320 of 19431 for Hemoglobin

  1. Fuchs Clinical Trials - Mayo Clinic Research

    ... hemoglobin A1c (HbA1c), and skin advanced glycation endproducts (AGE) and ... . Mayo Clinic Footer. Request Appointment · Give Now · Contact Us · About Mayo ...

  2. Impact Of Estradiol Addback - Mayo Clinic

    ... hemoglobin <12.0 gm/dL; Drug or alcohol abuse, psychosis, depression, mania or severe anxiety;; Acute or chronic organ-system disease;; Endocrinopathy, other ...

  3. A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia - Mayo Clinic

    Poorly controlled diabetes mellitus, defined as a hemoglobin A1C > 8%. Abnormal liver function: gamma-glutamyl transferase (GGT) > 1.5 × upper limit of ...

  4. Ixazomib Citrate, Pomalidomide, Dexamethasone, and Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dL. Total bilirubin ≤ 1.5 x the upper limit of the normal range (ULN) or if total bilirubin is > 1.5 x ULN, the direct bilirubin must ...

  5. Radiation Therapy and Cisplatin With or Without Surgery in Treating Patients With Stage III-IV Oropharyngeal Cancer - Mayo Clinic

    Hemoglobin ≥ 8.0 g/dl based upon CBC/differential (Note: The use of transfusion or other intervention to achieve hemoglobin [Hgb] ≥ 8.0 g/dl is acceptable) ...

  6. A Study to Evaluate the Effectiveness and Safety of P276-00 for Mantle Cell Lymphoma that has Returned and/or is Resistant to Treatment - Mayo Clinic

    Hemoglobin <8.0 gm/dL; Absolute neutrophil count <1000/mm3; Platelet count <50,000/mm3; Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) >3 ...

  7. CY 6031 Study Will Evaluate the Effects of Treatment With Aficamten (CK-3773274) Over a 24-week Period on Cardiopulmonary Exercise Capacity and Health Status in Patients With Symptomatic oHCM - Mayo Clinic

    - Hemoglobin ≥10g/dL at screening. - Respiratory exchange ratio (RER) ≥1.05 and pVO2 <80% predicted on the screening CPET per the core laboratory ...

  8. Intestinal Permeability and Gastroparesis - Clinical Trials

    Patients with uncontrolled diabetes mellitus (hemoglobin A1C > 10). Patients with prior surgery to the esophagus, stomach or duodenum. Patients taking ...

  9. Fuchs' Dystrophy Clinical Trials - Mayo Clinic Research

    ... hemoglobin A1c (HbA1c), and skin advanced glycation endproducts (AGE) and ... . Mayo Clinic Footer. Request Appointment · Give Now · Contact Us · About Mayo ...

  10. Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma - Mayo Clinic

    - ELIGIBILITY CRITERIA (STEP 1): Hemoglobin >= 9 g/dL - ELIGIBILITY CRITERIA (STEP 1): Creatinine clearance (CrCl) >= 30 mL/min - ELIGIBILITY CRITERIA (STEP ...